This activity is jointly provided by Postgraduate Institute for Medicine (PIM) and CMEology.

The Current Role of Plasma-Derived Therapies for Hemophilia A

Overview / Abstract:	Target Audience This accredited activity is designed to address the educational needs of specialists who care for patients with hemophilia A. Learning Objectives Upon completion of this activity, participants should be able to: Summarize best practices in controversial aspects of hemophilia A care Identify the current, evolving, and future roles for plasma-derived FVIII
Expiration	Nov 26, 2020
Discipline(s)	Nursing CNE, Physician CME
Credits / Hours	0.5
Accreditation	ACCME
Presenters / Authors / Faculty	Robert Sidonio, Jr., MD Assistant Professor of Pediatrics and Director of Clinical Operations Hemostasis and Thrombosis Program Emory University School of Medicine Aflac Cancer and Blood Disorders Center at Children’s Healthcare of Atlanta Guy Young, MD Director of the Hemostasis and Thrombosis Center Children’s Hospital Los Angeles Professor of Pediatrics University of Southern California Keck School of Medicine
Sponsors / Supporters / Grant Providers	Supported by an educational grant from Kedrion Biopharma Inc.
Keywords / Search Terms	Relias LLC Hematology, Relias LLC, Hemophilia A Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map